发明人黄志刚,高志强,赵玉洁. "Method for the Synthesis of 2-Chloro-1-(2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-5-yl)ethan-1-one" [P]. 中国发明专利, 专利号 CN 110990358 B, 授权公告日 2025-02-17.
发明人冯建国,唐晓军,周伟. "A Process for Preparing High-Purity 2-Chloro-1-(2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-5-yl)ethan-1-one" [P]. 中国发明专利, 专利号 CN 114004621 B, 授权公告日 2020-01-20.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2025, 815, 3117-3147.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2015, 751, 1731-1745.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of 2-Chloro-1-(2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-5-yl)ethan-1-one Using HRMS and NMR". Anal. Chem., 2022, 2191, 2454-2476.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2025, 2397, 9276-9294.